FolioLanternBeta
NTRANatera, Inc.

Solomon Moshkevich

President, Clinicaldiagnostics at Natera, Inc., as of Oct 2, 2026Sold $23.6M of stock in the past 12 months: 95% under a disclosed plan and 5% to cover taxes.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
107K
shares held after the latest filing, Natera, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
93K
shares sold, past 12 months
27
days with sales
$5.4M
largest single day, Jan 20, 2026
1
company filed for

Share of stake sold at Natera, Inc. is not shown: most of their shares vested during the period, so a percentage would mislead. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Oct 2025: $478K under a disclosed planOctNov 2025: $596K under a disclosed planNovDec 2025: $714K under a disclosed planDec 2025: $1.1M to cover taxesDecJan 2026: $6.7M under a disclosed plan$6.7MJanFeb 2026: $1.1M under a disclosed planFebMar 2026: $786K under a disclosed planMarApr 2026: $1.1M under a disclosed planAprMay 2026: $1.0M under a disclosed planMayJun 2026: $655K under a disclosed planJunJul 2026: $1.4M under a disclosed planJulAug 2026: $906K under a disclosed planAugSep 2026: $5.9M under a disclosed planSepOct 2026: $1.2M under a disclosed planOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Natera, Inc. (NTRA)President, ClinicaldiagnosticsJan 30, 2024Oct 2, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.